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Abstract
Objective: To retrospectively determine whether diffusion-weighted magnetic resonance imaging (DW-MRI) can help in differentiating between various tumors 
and inflammatory lesions in the head and neck. 
Materials/ methods: After obtaining ethics committee approval, a search was made in the radiology records for patients with diffusion- weighted MR imaging for 
inflammatory, benign and malignant lesions in the head and neck region, which were confirmed either by histopathology or by follow up for at least one year. Seventy-
two patients were included in this study. The lesions were grouped into malignant lesions, comprising primary carcinomas (n=17), metastasis (n=12) and lymphoma 
(n=12), benign tumors (n=24), inflammation (n=4) and miscellaneous benign lesions (n=3). Diffusion was assessed qualitatively by visual analysis and quantitatively 
by measuring the apparent diffusion coefficient (ADC) values. 
Results: Benign lesions had higher ADC values than malignant lesions: The mean value for benign tumors was 1.46 x 10-3 mm2/sec and for inflammatory lesions 
1.51 x 10-3 mm2/sec. Lymphomas showed a mean value of 0.56 x 10-3 mm2/sec. The values for carcinoma and metastasis were similar with 0.84 x 10-3 mm2/sec and 
0.81 x 10-3 mm2/sec respectively.
According to receiver operating characteristic (ROC) analysis, values higher than 1.03 x 10-3 mm2/sec were ideal for differentiation between benign lesions and 
malignant tumors with a sensitivity of 88% and specificity of 79%. Lymphomas had significantly lower ADC values than all other entities. 
Conclusion: DW-MRI can help in differentiation of inflammatory and benign lesions from malignant lesions of the head and neck.
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Introduction
Diffusion-weighted magnetic resonance imaging (DW-MRI), a 
functional MR imaging technique, is widely used for detection of acute 
stroke, myocardial ischemia, assessing different tumors (like liver, 
kidneys or prostate) and for assessing organ function and small bowel 
pathologies [1-7]. In the head and neck region, DW-MRI has been used 
for characterization of primary tumors, nodal metastasis, prediction 
and monitoring of treatment response, for differentiation between 
recurrent tumors and post-therapeutic changes or to study salivary 
gland function [8-11]. 
The radiological assessment of the head and neck area can be 
challenging due to its complex anatomy. Changes caused by tumors and 
inflammation can appear very similar, making it sometimes difficult to 
differentiate between them, especially if clinical signs of infection such 
as fever and accompanying changes in blood parameters are absent, 
as in many subacute and chronic infections or in granulomatous 
diseases. Tumors can also show infiltrative growth into the surrounding 
tissue, mimicking inflammation and a biopsy is often required for the 
diagnosis. The use of a non-invasive tool such as DW-MRI, if proven 
to be useful in this matter, can lead to a reduction in the number of 
biopsies required and also pinpoint suspicious areas where biopsies 
should be taken to reduce false negative results. 
Many publications show the benefits of DW-MRI in the 
differentiation between benign and malignant tumors, for detecting 
lymph node metastases and tumor recurrence [12-16] and for 
evaluation of inflammation in different areas of the body [17,18]. 
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However, there are limited studies evaluating inflammatory lesions 
in the head and neck region with DW-MRI [19-21], probably because 
inflammatory conditions are mostly only imaged when complications 
are suspected, and contrast-enhanced computed tomography (CT) is 
still more commonly used for this purpose.
Malignant lesions are usually hypercellular and show diffusion 
restriction with resulting lower apparent diffusion coefficient (ADC) 
values compared to benign lesions, which are less cellular. Inflammatory 
lesions are edematous and relatively hypocellular, which should allow 
more diffusion and therefore higher ADC values. We hypothesize, that 
these lesions can be differentiated with DW-MRI. The purpose of this 
study is to find out retrospectively whether quantitative and qualitative 
assessment of DW-MRI can help in the differentiation between various 
malignant and benign lesions (including inflammatory lesions) in the 




This is a retrospective study approved by the institutional review 
board; consent was waived because of the retrospective nature of the 
study. A search was made in the radiological database of our hospital 
(Centricity RIS-I, GE Healthcare, Milwaukee, Wisconsin, USA) and 
all patients with tumors or inflammatory changes, who had diagnostic 
quality MR examinations, including diffusion-weighted sequences of 
the neck, from the beginning of 2007 to the end of 2013, were included 
in the study. The benign or malignant nature of the lesions was proven 
either with histopathology after surgery or biopsy or after a follow up of 
at least one year for benign lesions. This search resulted in 72 patients 
(24 females, 48 males, age range: 16-95 years, mean age: 58.8 years), 
who were all included in the present study (supplementary Table 1).
MR imaging
MR imaging was performed at 1.5T (Magnetom AERA, Siemens 
Healthcare, Erlangen, Germany) with a standard receive-only head and 
neck coil. Due to the different clinical presentations of the patients, 
different imaging protocols were used and so the sequences varied. 
However, all included at least the following sequences:
A coronal turbo inversion recovery sequence (voxel size: 1.0 x 1.0 
x 4.0 mm, FoV read: 260 mm, slice thickness: 4.0 mm, repetition time 
/ echo time: 4000 ms / 48 ms), an axial T1-weighted (T1-w) sequence 
(0.3 x 0.3 x 3.0 mm, 220 mm, 3.0 mm, 580 ms / 12 ms), an axial T2-w 
sequence (0.6 x 0.6 x 3.0 mm, 220 mm, 3.0 mm, 4000 ms / 84 ms) and 
DW-images in the axial plane (1.3 x 1.3 x 4.0 mm, 250 mm, 4.0 mm, 
3000 ms / 111 ms). After injection of contrast media, T1-w fat-saturated 
sequences in the axial plane (0.4 x 0.4 x 3.0 mm, 220 mm, 3.0 mm, 533 
ms / 12 ms) and in the coronal plane (0.5 x 0.5 x 3.0 mm, 300 mm, 3.0 
mm, 509 ms / 9.6 ms) were acquired. Contrast agents used were either 
Gadovist (Bayer, Zürich, Switzerland) for patients with normal kidney 
function at a dose of 0.1 ml per kilogram body weight or Dotarem 
(Bracco SpA, Milano, Italy) for patients with impaired kidney function 
at a dose of 0.2 ml per kilogram body weight.
A minimum of two b-values to a maximum of six b-values were 
used with b-values ranging from 0, 50, 100, 150, 300, 400, 500, 600, 
800, 900 and 1000 mm2/sec depending on the MR protocol used. The 
highest b-value of each study was used to calculate the ADC (either 800 
or 1000 mm2/sec).
Image analysis
Images were analyzed qualitatively and quantitatively in consensus, 
by two radiologists with 20 years’ (HT) respectively with 13 years’ 
(DWT) experience in MR imaging of the head and neck, blinded to 
the final diagnosis. The signal intensity of the lesions on T1-w and 
T2-w sequences relative to the adjacent skeletal muscle and presence of 
contrast enhancement were also documented.  
Qualitative analysis was performed by visual assessment of the 
high b-value images and the corresponding ADC maps in conjunction 
with the morphological images. Diffusion restriction was present when 
there was a high signal in the high b-value image with corresponding 
low signal on the ADC map. High signal on the high b-value images 
with high value in the corresponding ADC map was interpreted as T2-
shine-through and not as diffusion restriction. Low signal on both the 
high b-value images and ADC maps was interpreted as an absence of 
diffusion restriction.
Quantitative analysis consisted of ADC value measurement. Maps 
of the ADC were automatically obtained from the diffusion-weighted 
images by use of a multiple point regression method using the following 
equation: Ib =I0 x exp (-b × ADC), where I0 and Ib are the signal intensity 
value of each pixel in a region of interest at a b-value of 0 sec/mm2 
respectively b sec/mm2. The ADC values were measured by placing a 
circular region of interest (ROI) in each area of pathological change. 
While placing the ROI in the lesions, areas with obvious contrast 
enhancement in the corresponding T1w-sequences were targeted to 
exclusively include solid tumor mass and avoid areas of necrosis.
Histopathology
Imaging results were compared to histopathological results and 
/ or follow-up exams. In sixty-two patients, including all the patients 
with malignancies, histopathological correlation for the lesions were 
available (19 surgeries and 43 biopsies). The diagnoses in the remaining 
ten patients with benign tumors, inflammatory or miscellaneous lesions 
were confirmed by a follow-up examination after at least one year.
Statistical analysis
A power analysis with the current values, i.e. 41 malignant lesions 
and 31 benign lesions, including benign tumors, inflammatory and 
miscellaneous lesions, and a standard deviation of approximately 0.2 
(13%), taken from the literature (22, 23), yields that an ADC difference 
of 0.14 could be detected at a significance level of 0.05 and a statistical 
power of 0.8. In view of previously detected ADC differences, the 
sample size was therefore considered sufficient. 
Statistical analysis was performed by use of a Kruskal-Wallis test 
to find out whether there were any significant differences in ADC 
values between the groups. In a second step the groups were compared 
pairwise by use of the Mann-Whitney-U test to quantify statistical 
differences.
All statistical tests were two-sided, a p-value of less than 0.05 
was considered statistically significant after corrections for multiple 
comparisons. Box-whisker plots were used to visualize group-wise 
differences in quantitative diffusion parameters. Optimal threshold 
values to discriminate between the groups were determined using 
receiver operating characteristics (ROC) curves, attributing equal 
weight to sensitivity and specificity. The value that corresponded with 
the ROC-curve nearest to the top left-hand corner was considered the 
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optimal threshold-value. Statistical analysis was performed with SPSS, 
version 12.0.1 (SPSS, Chicago, IL, USA) and Excel 2011 (Microsoft, 
Redmond, WA, USA).
Results
Out of the 72 patients included in this study, 41 patients had 
malignant lesions (57%) and 31 had benign lesions (43%). Malignant 
lesions included primary carcinomas (n=17), lymphomas (n=12) and 
cervical metastases (n=12).
Primary carcinomas were located in the oropharynx (n=6), the 
nasopharynx (n=4), the hypopharynx (n=3), in the parotid gland 
(n=2), the masticator space (n=1) or the thyroid gland (n=1) and 
consisted of SCC (n=11), undifferentiated nasopharyngeal carcinoma 
(n=2), adenocarcinoma (n=2) and papillary carcinoma of the thyroid 
gland (n=2).
Cervical metastases originated from various tumors: SCC of the 
oropharynx (n=4), the larynx (n=2), adenocarcinoma of the parotid 
gland (n=1), nasopharyngeal carcinoma of the maxillary sinus 
(n=1), neuroendocrine tumor of the thymus (n=1), infratemporal 
melanoma (n=1), parapharyngeal synovial cell sarcoma (n=1) and from 
retropharyngeal malignant nerve sheath tumor (n=1).
Benign lesions consisted of benign tumors (n=24), inflammation 
(n=4) and benign miscellaneous lesions consisting of sarcoidosis (n=1), 
Wegeners granulomatosis (n=1) and a case of Rosai-Dorfman disease 
(n=1). 
Benign tumors included pleomorphic adenoma (n=11), 
hemangioma (n=3), Warthin tumors (n=2), fibrolipoma (n=1), lipoma 
(n=1), schwannoma (n=1), meningioma (n=1), glomus tumor (n=1), 
odontogenic myxoma of the maxilla (n=1), lymphangioma (n=1) and 
a lymphoepithelial cyst (n=1). The inflammatory lesions included 
a case of myositis of the temporalis muscle (n=1), an inflammatory 
pseudotumor of the pterygopalatine fossa (n=1), focal parotitis (n=1) 
and a diffuse inflammation of the cheek after dental extraction (n=1).
Image analysis
The MRI appearances of the lesions are presented in Table 1 along 
with the results of the qualitative and quantitative analysis. Most lesions 
were hypointense compared to adjacent skeletal muscle on T1-w 
sequences and hyperintense on T2-w sequences with varying amounts 
of contrast enhancement as shown in the table.
Qualitative evaluation of DW-MRI showed that 40 / 41 of 
malignant lesions had restricted diffusion. The only exception was a 
case of papillary carcinoma of the thyroid gland. Diffusion restriction 
was most marked in lymphoma (Figure 1). 
Most benign tumors did not show any diffusion restriction (Figure 
2). Diffusion restriction was present in schwannoma, meningioma and 
Warthin tumors. Focal areas of restricted diffusion were also seen in a 
cystic lymphangioma and one pleomorphic adenoma.  
The inflammatory and benign miscellaneous lesions did not show 
any quantifiable diffusion restriction (Figure 3). 
Pathology T1 T2 CE High b-value ADC map DR ADC range ADC mean
Malignant lesions (n= 41) 0.85
Carcinoma 
 (n=17)
n=16 ↓ ↑ +++ ↑ ↓ + 0.39 - 1.30 0.83
n=1 ↓ ↑ +++ ↑ ↑  - / 1.02
Metastasis (n=12) ↓ ↑ +++ ↑ ↓ + 0.42- 1.41 0.81
Lymphoma (n=12) ↓ ↑ +++ ↑ ↓ + 0.43 - 0.79 0.56
Benign tumors (n= 24) 1.46
Adenoma (n=11) n=10 ↓ ↑ ++ ↑ ↑ - 1.14- 2.25 1.60
n=1 ↓ ↑ ++ ↑ ↓ + / 1.94
Hemangioma (n=3) ↓ ↑ ++ ↑ ↑ - 1.14 - 2.26 1.63
Warthin tumor (n=2) ↓ ↓ ++ ↑ ↓ + 0.60 - 0.78 0.69
(Fibro)Lipoma (n=2) ↑ ↑ + ↑ ↑ - 0.84 - 1.67 1.26
Schwannoma (n=1) ↓ ↑ ++ ↑ ↓ + / 1.60
Meningioma (n=1) ↓ ↑ ++ ↑ ↓ + / 0.76
Glomus tumor (n=1) ↓ ↑ + ↑ ↑ - / 1.24
Myxoma (n=1) ↓ ↑ + ↑ ↑ - / 2.07
Lymphangioma (n=1) ↓ ↑ + ↑ ↓ + / 0.78
Lymphoepithelial Cyst (n=1) ↓ ↑ + ↑ ↑ - / 2.37
Pathology T1 T2 CE High b-value ADC map DR ADC range ADC mean 
Inflammatory lesions (n=4) 1.51
Myositis (n=1) ↓ ↑ +++ ↑ ↑ - / 1.54
Inflammatory Pseudotumor (n=1) ↓ ↑ +++ ↑ ↑ - / 1.51
Focal parotitis (n=1) ↓ ↑ +++ ↑ ↑ - / 1.04
Posttherapeutic inflammation (n=1) ↓ ↑ ++ ↑ ↑ - / 1.97
Miscellaneous lesions (n=3) 1.11
Wegeners disease (n=1) ↑ ↓ +++ ↑ ↑ - / 1.22
Sarcoidosis (n=1) ↓ ↑ +++ ↑ ↑ - / 1.17
Rosai-dorfman-disease (n=1) ↓ ↑ + ↑ ↑ - / 0.95
 - CE contrast enhancement; + mild, ++ moderate, +++ strong enhancement
 - T1 (weighted); T2 (weighted); ↓ hypointense signal intensity (in comparison to adjacent muscle), ↑ hyperintense signal intensity (in comparison to adjacent muscle)
 - DR diffusion restriction: - negative / + positive
 - High b-value: image at 1000 mm2/s resp. 800 mm2/s 
 - ADC unit: x 10-3 mm2/s
Table 1. Imaging appearance of the lesions with qualitative and quantitative evaluation of DW-MRI 
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A   B    C      D  
Figure 1. Axial MRI images of an 88-year-old male with lymphoma of the right mandible (arrows)
(A) T2-w image showing a lesion of the right mandible with intermediate signal intensity. (B) T1-w fat sat image with contrast media showing inhomogenous enhancement of the lesion. (C) 
High b-value DW-MR image showing high signal in the periphery with corresponding low signal on the ADC map. (D) The ADC value was 0.64 x 10-3 mm2/sec
Figure 2. Axial MR images of a 52-year-old male with a fibrolipoma in the left-sided autochthonous muscles of the neck (arrows)
(A) T2-w image showing a slightly hyperintense lesion involving the adjacent muscles (arrows). (B) On the T1-w image, the lesion is slightly hyperintense to the adjacent muscles. (C) The 
high b-value image shows hyperintense signal, which remains high on the corresponding ADC map (D)
A  B   C   D   
A   B   C   D   
Figure 3. Axial MR images of a 62-year-old female patient with an inflammatory pseudotumor in the right pterygopalatine fossa and adjacent infratemporal fossa (asterisk)
(A) T2-w image showing hyperintense signal in the right pterygopalatine and adjacent infratemporal fossa. (B) T1-w image before contrast shows low signal intensity in the same area and 
(C) T1-w fat sat image after injection of contrast media, which shows strong homogenous contrast enhancement. (D) High b-value DW-MR image showing absence of high signal intensity 
in the same area, indicating an absence of diffusion restriction
The sole use of qualitative analysis to detect diffusion restriction 
as an indicator of malignancy resulted in a sensitivity of 97.4% (40 / 
41 malignant lesions showed restricted diffusion) and a specificity of 
80.6% (6 / 31 benign lesions showed restricted diffusion).
Quantitative evaluation was based on the ADC values. Primary 
carcinomas had a mean ADC value of (0.84 ± 0.23 [standard deviation]) 
x 10-3 mm2/sec (range: 0.39 – 1.30 x 10-3 mm2/sec) and cervical 
metastases a mean value of (0.81 ± 0.27) x 10-3 mm2/sec with a range of 
0.42 – 1.41 10-3 mm2/sec. Lymphomas had a mean ADC value of (0.56 
± 0.1) x 10-3 mm2/sec (range: 0.43 – 0.79 x 10-3 mm2/sec). Benign tumors 
showed a mean ADC value of (1.46 ± 0.52) x 10-3 mm2/sec (range: 0.69 
– 2.37 x 10-3 mm2/sec).
Inflammatory lesions showed a mean ADC value of (1.51 ± 0.38) 
x 10-3 mm2/sec (range: 1.04 - 1.97 x 10-3 mm2/sec). The results are 
presented graphically in Figure 4.
Statistical analysis
Comparing the different groups to one another, the Mann-
Whitney-U test showed that benign tumors had significantly higher 
ADC values compared to carcinomas (p= 0.004), as well as to metastases 
(p=0.003) and to lymphomas (p=0.00004).
Based on the ADC values, inflammation could be clearly 
differentiated from lymphomas after conservative Bonferroni correction 
for multiple comparisons (p= 0.036). Furthermore, there were only 
borderline significant differences (p < 0.06) between inflammation 
and carcinomas (p= 0.055), as well as between inflammation and 
metastases (p= .053). Most likely this was due to the small sample size 
of inflammatory lesions (n= 4). There was no statistical significant 
difference between inflammatory lesions and benign tumors.
ROC analysis revealed the optimal threshold value to distinguish 
between benign lesions, including inflammatory and miscellaneous 
lesions, and malignant tumors to be 1.03 x 10-3 mm2/sec with a 
sensitivity of 88% and a specificity of 79% for the ADC values (Figure 
5A). The area under the curve (AUC) was 0.89, suggesting a good 
quality of the analysis.
Primary carcinomas and cervical metastases in the neck area had 
similar ADC values, which is logical since both groups consist of the 
same tumor entities.
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ADC values of lymphomas were the lowest among all the lesions 
and there was a significant difference between the ADC values of 
lymphomas compared to primary carcinomas (p= 0.009) and between 
lymphomas compared to metastases (p= 0.047). According to the 
ROC analysis, a threshold value of 0.64 x 10-3 mm2/sec was optimal for 
differentiating lymphomas from primary carcinomas with a sensitivity 
of 92% and a specificity of 88%. The same threshold value could be used 
for differentiation between lymphomas and cervical metastases with a 
sensitivity of 92% and a specificity of 75% (Figure 5b and 5c). The AUC 
for the ROC analysis between lymphoma and carcinoma was 0.87 and 
for the analysis between lymphoma and metastasis 0.84, suggesting a 
good quality for both analyses. The pairwise comparisons are shown in 
Figure 6 and the corresponding p-values in Table 2.
Discussion
The results of the current study show that DW-MRI can differentiate 
between benign lesions, inflammation and malignant tumors. Visual 
assessment of the diffusion-weighted sequences alone proved to be very 
effective in detection of malignant lesions, as seen in previous studies 
[21-26]. However, visual assessment is subjective, is highly dependent 
on the readers’ experience and lastly, comparison with other studies is 
difficult. ADC values on the other hand are quantitative, and therefore 
objective, allowing comparison with other studies.
Qualitative analysis proved to be very useful in differentiation 
between inflammatory lesions and malignant tumors as most 
inflammatory lesions did not show restricted diffusion and malignant 
tumors mostly did. In this study, the differences in ADC values between 
inflammatory and malignant lesions were not statistically significant 
after conservative Bonferroni correction, most likely due to the small 
number of subjects in the inflammation group. Still, a clear trend 
towards higher ADC values in inflammatory lesions was seen compared 
to the malignant lesions of the head and neck area.
Based on ADC values, lymphomas could be easily differentiated 
from inflammatory lesions in a statistically significant way. This finding 
is in keeping with the work of Sepahdari et al., who compared ADC 
values of lymphomas to inflammatory pseudotumors of the orbit and 
pointed out significant differences between these two entities [20]. This 
can be easily explained by the hypercellularity of lymphomas limiting 
diffusion and the relative hypocellularity of edematous inflammatory 
lesions allowing more diffusion. Lymphomas could furthermore be 
clearly differentiated from the other benign and malignant lesions as 
well, which is also well in keeping with the literature [22-26]. Although 
a decrease in the ADC values in fungus infection of the masticator 
space has been reported in literature [21], we did not have any such case 
in this patient collective. However it should be kept in mind and this 
highlights the point that diffusion weighted imaging should always be 
interpreted in conjunction with the other MRI images and the clinical 
context.
A ROC analysis to determine cut-off values to differentiate 
between inflammatory and malignant lesions could unfortunately not 
be performed due to the small sample size of inflammatory lesions. 
Nevertheless, ROC analysis revealed an optimal threshold value for 
the differentiation between malignant and all benign lesions, including 




Lymphoma Benign Tumor 0.000036
Lymphoma Inflammation 0.036
Metastasis Carcinoma 1
Metastasis Benign Tumor 0.0029
Metastasis Inflammation 0.053
Carcinoma Benign Tumor 0.0035
Carcinoma Inflammation 0.055
Benign Tumor Inflammation 1
Table 2. Paired comparisons between the different entities with the respective p-values
- bold: statistically significant
- normal: no statistical significance
Figure 4. Boxplot showing the distribution of ADC values for different pathologies
   
Figure 5. ROC-Curves for the ADC-values for the discrimination between
a. malignant and benign tumors
b. lymphomas and metastases
c. lymphomas and primary carcinomas
Figure 6. Paired comparison between the different entities
Green lines: significant statistical differences after Bonferroni correction for multiple 
comparisons
Red lines: significant statistical differences before Bonferroni correction for multiple 
comparisons
Absence of lines: No statistical difference
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is highly concordant with the results of Sepahdari et al. who claimed a 
value 1.0 x 10-3 mm2/sec to be the optimal cut-off value for this matter 
[20] and is also in agreement with most of the pre-existing data [22-28]. 
The most important limitation of this study is the small sample size 
of the inflammation group, since CT is still primarily used for imaging 
complications of inflammation in the head and neck area. Still, a strong 
trend towards higher ADC values in inflammatory lesions could be 
seen before Bonferroni corrections. 
Another limitation to this study was the inclusion of different 
imaging protocols with variable b- values. However, despite this 
limitation, statistically significant results were obtained as mentioned 
above, consistent with results from previous studies. Thus, it is probable 
that a consistent DW-MRI protocol, ideally including more b-values 
and allowing the separation of diffusion and perfusion contributions, 
would result in even stronger differences between the groups.
Lastly, although most benign tumors are usually relatively 
hypocellular and malignant lesions are usually hypercellular, a few 
benign tumors can show diffusion restriction, e.g. Warthin tumors 
due to epithelial and lymphoid stroma with microscopic slitlike cysts 
containing proteinous fluid [29]. Therefore, biopsies or fine needle 
aspirations cannot always be avoided. The use of advanced diffusion 
weighted imaging, with new post-processing methods such as 
diffusion kurtosis imaging, diffusion tensor imaging or diffusion tensor 
tractography [30] has the potential to better characterize the different 
types of head and neck lesions compared with the whole-lesion mean 
ADC values.
In summary, our results show that qualitative analysis of diffusion-
weighted imaging is highly accurate in the differentiation between 
benign and malignant pathologies in the head and neck area and 
should be performed routinely. Despite the differences in the imaging 
protocols, this study shows that there were significant differences in 
the ADC values between the various pathologies and these results are 
concordant with most publications regarding this matter despite the 
fact that examinations with variable b-values were included in the study.
There is a clear trend towards higher ADC values in inflammatory 
lesions compared to malignant lesions, but this was not statistically 
significant after Bonferroni correction for multiple comparisons. It 
will be the task of upcoming studies to validate the observed trends 
by including a higher number of inflammatory lesions and also 
incorporating advanced diffusion imaging, which has the potential to 
further improve characterization of different types of lesions.
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